BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32056305)

  • 21. Long Noncoding RNA MALAT1 Contributes to Sorafenib Resistance by Targeting miR-140-5p/Aurora-A Signaling in Hepatocellular Carcinoma.
    Fan L; Huang X; Chen J; Zhang K; Gu YH; Sun J; Cui SY
    Mol Cancer Ther; 2020 May; 19(5):1197-1209. PubMed ID: 32220970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long noncoding RNA LINC00324 exerts protumorigenic effects on liver cancer stem cells by upregulating fas ligand via PU box binding protein.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    FASEB J; 2020 Apr; 34(4):5800-5817. PubMed ID: 32128906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA DLX6-AS1 promotes liver cancer by increasing the expression of WEE1 via targeting miR-424-5p.
    Li D; Tang X; Li M; Zheng Y
    J Cell Biochem; 2019 Aug; 120(8):12290-12299. PubMed ID: 30805988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma.
    Tang YH; He GL; Huang SZ; Zhong KB; Liao H; Cai L; Gao Y; Peng ZW; Fu SJ
    Mol Oncol; 2019 May; 13(5):1296-1310. PubMed ID: 30943320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA THEMIS2-211, a tumor-originated circulating exosomal biomarker, promotes the growth and metastasis of hepatocellular carcinoma by functioning as a competing endogenous RNA.
    Yao J; Hua X; Shi J; Hu X; Lui K; He K; Mai J; Lan T; Lu M
    FASEB J; 2022 Apr; 36(4):e22238. PubMed ID: 35224785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression.
    Gao W; Chen X; Chi W; Xue M
    Int J Mol Med; 2020 Nov; 46(5):1743-1754. PubMed ID: 33000222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrantly activated Gli2-KIF20A axis is crucial for growth of hepatocellular carcinoma and predicts poor prognosis.
    Shi C; Huang D; Lu N; Chen D; Zhang M; Yan Y; Deng L; Lu Q; Lu H; Luo S
    Oncotarget; 2016 May; 7(18):26206-19. PubMed ID: 27036048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA sequencing reveals the long noncoding RNA and mRNA profiles and identifies long non-coding RNA TSPAN12 as a potential microvascular invasion-related biomarker in hepatocellular carcinoma.
    Lu J; Li B; Xiong X; Cheng N
    Biomed Pharmacother; 2020 Jun; 126():110111. PubMed ID: 32222644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
    Zhao X; Liu Y; Yu S
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
    Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
    J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
    Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SNHG16 as the miRNA let-7b-5p sponge facilitates the G2/M and epithelial-mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma.
    Li S; Peng F; Ning Y; Jiang P; Peng J; Ding X; Zhang J; Jiang T; Xiang S
    J Cell Biochem; 2020 Mar; 121(3):2543-2558. PubMed ID: 31696971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PITPNA-AS1 abrogates the inhibition of miR-876-5p on WNT5A to facilitate hepatocellular carcinoma progression.
    Sun J; Zhang Y; Li B; Dong Y; Sun C; Zhang F; Jin L; Chen D; Wang W
    Cell Death Dis; 2019 Nov; 10(11):844. PubMed ID: 31700026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.
    Huang X; Liu F; Zhu C; Cai J; Wang H; Wang X; He S; Liu C; Yao L; Ding Z; Zhang Y; Zhang T
    Dig Dis Sci; 2014 Apr; 59(4):795-806. PubMed ID: 24368420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis.
    Zhang M; Wang W; Li T; Yu X; Zhu Y; Ding F; Li D; Yang T
    Biomed Pharmacother; 2016 May; 80():73-79. PubMed ID: 27133041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA DCST1-AS1 functions as a competing endogenous RNA to regulate FAIM2 expression by sponging miR-1254 in hepatocellular carcinoma.
    Chen J; Wu D; Zhang Y; Yang Y; Duan Y; An Y
    Clin Sci (Lond); 2019 Jan; 133(2):367-379. PubMed ID: 30617187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma.
    Fu X; Zhu Y; Zheng B; Zou Y; Wang C; Wu P; Wang J; Chen H; Du P; Liang B; Fang L
    Int J Oncol; 2018 Jun; 52(6):1912-1922. PubMed ID: 29620256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA SNHG3 Promotes Hepatocellular Tumorigenesis by Targeting miR-326.
    Zhao Q; Wu C; Wang J; Li X; Fan Y; Gao S; Wang K
    Tohoku J Exp Med; 2019 Sep; 249(1):43-56. PubMed ID: 31548493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.